[Drug therapy prevention of pancreatic fistula after pancreaticoduodenectomy].
Slim
K
K
Service de chirurgie générale et digestive, 63058, Clermont-Ferrand, France. kslim@chu-clermontferrand.fr <kslim@chu-clermontferrand.fr>
Le Borgne
J
J
D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010185:Pancreatic Fistula / Q000209:etiology* / Q000517:prevention & control*; D010190:Pancreatic Neoplasms / Q000601:surgery; D016577:Pancreaticoduodenectomy / Q000009:adverse effects*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D011182:Postoperative Care / Q000379:methods; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide